Search hospitals > Maryland > Rosedale
Elman Retina Group, PA
Claim this profileRosedale, Maryland 21237
Global Leader in Diabetic Macular Edema
Global Leader in Diabetic Retinopathy
Conducts research for Age-Related Macular Degeneration
Conducts research for Macular Degeneration
Conducts research for Edema
32 reported clinical trials
1 medical researcher
Summary
Elman Retina Group, PA is a medical facility located in Rosedale, Maryland. This center is recognized for care of Diabetic Macular Edema, Diabetic Retinopathy, Age-Related Macular Degeneration, Macular Degeneration, Edema and other specialties. Elman Retina Group, PA is involved with conducting 32 clinical trials across 26 conditions. There are 1 research doctors associated with this hospital, such as Michael Elman, MD.Top PIs
Clinical Trials running at Elman Retina Group, PA
Diabetic Retinopathy
Macular Pucker
Faricimab + PRP vs. Vitrectomy + Endolaser
for Diabetic Retinopathy
This randomized trial will compare treatment strategies for proliferative diabetic retinopathy (PDR). Participants will receive either combination a of faricimab + PRP or vitrectomy + endolaser. The participants will be followed for 3 years. The study will evaluate long-term visual acuity as well as differences in number of injections, procedures, and complications during follow-up (after completion of randomization treatment), and cost.
Recruiting2 awards Phase 33 criteria
Fenofibrate
for Diabetic Retinopathy
This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with mild to moderately severe non-proliferative DR (NPDR) and no CI-DME at baseline. In addition to evaluating efficacy, this study aims to evaluate the feasibility of a model for ophthalmologists to prescribe or collaborate with a primary care provider such as an internist/endocrinologist to prescribe and monitor the drug safely. If this study demonstrates that fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community of retina specialists, a new strategy to prevent vision threatening complications of diabetes could be widely adopted. Widespread use of an oral agent effective at reducing worsening of DR would decrease the numbers of patients who undergo more invasive and much more expensive treatment for DR and who are consequently at risk for side effects that adversely affect visual function. This study will also assess the relationship of glycemic variability, as measured by continuous glucose monitoring with DR outcomes. Ancillary studies will characterize functional and structural outcomes in this cohort.
Recruiting1 award Phase 35 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Elman Retina Group, PA?
Elman Retina Group, PA is a medical facility located in Rosedale, Maryland. This center is recognized for care of Diabetic Macular Edema, Diabetic Retinopathy, Age-Related Macular Degeneration, Macular Degeneration, Edema and other specialties. Elman Retina Group, PA is involved with conducting 32 clinical trials across 26 conditions. There are 1 research doctors associated with this hospital, such as Michael Elman, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.